Nov 26, 2025 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – November 26, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”), announces the release of its condensed interim...
Oct 14, 2025 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – October 14, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”), is pleased to announce that it is arranging a non-brokered...
Oct 8, 2025 | Press Releases
PITTSBURGH, Pa. and TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) — Sharp Therapeutics Corp. (“Sharp” or the “Company”) (TSX-V: SHRX) (OTCQB: SHRXF), a biotechnology company developing small-molecule therapeutics for genetic diseases, today...
Aug 29, 2025 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – August 29, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) announces the release of its condensed interim...
Jul 29, 2025 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – July 29, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (“Sharp” or the “Company”), a preclinical-stage biotechnology company developing small molecule...